scholarly article | Q13442814 |
P50 | author | Jan Willem Cohen Tervaert | Q60901166 |
P2093 | author name string | Jan Damoiseaux | |
Pieter van Paassen | |||
Jesse Drijkoningen | |||
P2860 | cites work | The antiphospholipid syndrome | Q77739053 |
The antiphospholipid/cofactor syndrome: results of routine screening for antibodies to beta2-GPI upon suspicion of the antiphospholipid syndrome | Q81582414 | ||
Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H) | Q24558202 | ||
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
The concept and classification of antiphospholipid/cofactor syndromes | Q41197406 | ||
Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor | Q68090535 | ||
Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease | Q68091809 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1407-1408 | |
P577 | publication date | 2007-10-01 | |
P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
P1476 | title | Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteria | |
P478 | volume | 66 |
Q46271966 | Silicone implant incompatibility syndrome (SIIS): a frequent cause of ASIA (Shoenfeld's syndrome). |
Q33592080 | Vitamin D deficiency as a risk factor for the development of autoantibodies in patients with ASIA and silicone breast implants: a cohort study and review of the literature |
Search more.